Abstract
Pazopanib (Votrient (R)), an orally administered multi-targeted tyrosine kinase inhibitor that predominantly inhibits vascular endothelial growth fact......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
